Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% sodium chloride2件: Chloride ion,
Sodium chloride		1件: D02056 --4件: 6, 14, 51, 53
210% intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---1件: 14
310% liquid formulation of human immunoglobulin----1件: 14
4: immunoglobulina umana normale 10% per somministrazione endovenosa----1件: 14
5Act-HiB1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen---4件: 14, 61, 62, 222
6Acthar1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222
7Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14
8Anti-C5 antibody----4件: 11, 14, 62, 109
9Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285
10ARGX-113----4件: 11, 14, 35, 63
11ARGX-117----1件: 14
12ARGX-117 IV----1件: 14
13Autologous Hematopoietic Stem Cell Transplantation----7件: 11, 13, 14, 28, 49, 51, 84
14Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14
15Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)1件: Human immunoglobulin G---1件: 14
16BIVV020----2件: 14, 61
17BIVV020/SAR445088----1件: 14
18Carmustine1件: Carmustine1件: D00254 --5件: 11, 13, 14, 28, 60
19Chloride1件: Chloride ion---29件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338
20Clorfenamina1件: Chlorpheniramine4件: D00665 ,
D00668 ,
D07398 ,
D07803 		1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14
21CLORFENAMINA MALEATO1件: Chlorpheniramine4件: D00665 ,
D00668 ,
D07398 ,
D07803 		1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 14
22Cyclophosphamide1件: Cyclophosphamide2件: D00287 ,
D07760 		--45件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331
23Cytarabine1件: Cytarabine3件: D00168 ,
D03046 ,
D03637 		--7件: 11, 13, 14, 25, 49, 60, 65
24Dexamethasone1件: Dexamethasone9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
25ECULIZUMAB1件: Eculizumab1件: D03940 1件: C5 💬10件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222
26EFGARTIGIMOD ALFA1件: Efgartigimod alfa1件: D11876 1件: FCGRT 💬-4件: 11, 14, 35, 63
27Efgartigimod PH20 SC----4件: 11, 14, 35, 63
28Efgartigimod PH20 SC in stage B----1件: 14
29Etoposide1件: Etoposide2件: D00125 ,
D04107 		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331
30FAMPRIDINE1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
31FAMPYRA1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14
32Fibrinogen1件: Fibrinogen human---3件: 14, 65, 288
33Fibrinogen concentrate1件: Fibrinogen human---1件: 14
34FINGOLIMOD1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156
35FINGOLIMOD HYDROCHLORIDE1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14
36Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS)1件: Human immunoglobulin G---3件: 14, 43, 45
37FTY720----2件: 13, 14
38FTY720I----1件: 14
39Gammanorm----2件: 14, 65
40Gilenya----3件: 2, 13, 14
41GILENYA 0,5 mg cápsulas duras1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 14
42Group C meningococcal conjugate vaccine----1件: 14
43H.P. Acthar® Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 14
44HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---2件: 13, 14
45Haemophilus type b vaccine (conjugated)----1件: 14
46Hematopoietic Stem Cell Transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285
47Hidrocloruro de fingolimod1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14
48Hizentra1件: Human immunoglobulin G---4件: 14, 50, 51, 65
49Hizentra®1件: Human immunoglobulin G---2件: 14, 65
50HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G---4件: 14, 50, 63, 65
51Human normal 10% immunoglobulin for intravenous administration1件: Human immunoglobulin G---1件: 14
52Human normal 10% immunoglobulin for intravenous administrationn1件: Human immunoglobulin G---1件: 14
53Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65
54HUMAN NORMAL IMMUNOGLOBULIN (IV)1件: Human immunoglobulin G---4件: 11, 14, 63, 65
55Human normal immunoglobulin (IVIg)1件: Human immunoglobulin G---3件: 14, 50, 65
56Human normal immunoglobulin (SCIg)1件: Human immunoglobulin G---1件: 14
57Human normal immunoglobulin for intravenous administration1件: Human immunoglobulin G---3件: 14, 51, 65
58Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65
59Hyaluronidase1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--5件: 14, 28, 51, 65, 331
60HyQvia1件: Hyaluronidase (human recombinant)---2件: 14, 65
61I10----1件: 14
62I10E----3件: 14, 63, 65
63IGIV, 10%----2件: 14, 65
64IgPro10----3件: 14, 51, 65
65IgPro20----4件: 14, 50, 51, 65
66IgPro20 (high dose)----1件: 14
67IgPro20 (low dose)----1件: 14
68IGVENA*FL 200ML 10G+SET----2件: 14, 50
69Immune globulin----3件: 11, 13, 14
70Immune Globulin 10% Intravenous Solution----1件: 14
71Immune Globulin Intravenous (human), 10%----2件: 14, 65
72Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified----1件: 14
73Immune Globulin Subcutaneous (Human)----2件: 14, 65
74Immunoadsorption----2件: 13, 14
75Immunoglobulin----3件: 13, 14, 63
76IMMUNOGLOBULIN G----8件: 2, 11, 13, 14, 49, 50, 63, 65
77Immunoglobulin perfusion----1件: 14
78IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa----1件: 14
79Immunoglobuline G----1件: 14
80Immunoglobulins----1件: 14
81Immunoglobulins, normal human, for extravascular adm.----1件: 14
82Immunoglobulins, normal human, for intravascular adm.----2件: 14, 15
83Intratect----4件: 13, 14, 35, 65
84Intravenous Immunoglobulin----8件: 13, 14, 35, 38, 39, 49, 51, 309
85Intravenous immunoglobulin (IVIg)1件: Human immunoglobulin G---4件: 14, 17, 164, 296
86IQYMUNE----1件: 14
87IVIG1件: Human immunoglobulin G---8件: 11, 13, 14, 17, 35, 50, 51, 65
88J07AH07----1件: 14
89KIOVIG1件: Human immunoglobulin G---2件: 14, 65
90KIOVIG 100 mg/ml solution for infusion1件: Human immunoglobulin G---2件: 14, 65
91Lipoic acid1件: Lipoic acid2件: D00048 ,
D00086 		--5件: 2, 5, 13, 14, 20
92MabThera1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271
93MABTHERA - 1 FIALA 500 MG 50 ML1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 14, 53
94MD1003----5件: 2, 10, 13, 14, 20
95Melphalan1件: Melphalan1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
96Menjugate----1件: 14
97Methylprednisolon1件: Methylprednisolone6件: D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 13, 14, 51, 66
98Methylprednisolon (Solu-Medrol)1件: Methylprednisolone6件: D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14
99Methylprednisolone1件: Methylprednisolone6件: D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
100Methylprednisolone (Solu-Medrol)1件: Methylprednisolone6件: D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14
101Metilprednisolone sodio succinato----3件: 13, 14, 56
102N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14
103NewGam----3件: 14, 63, 65
104NPB-01----3件: 13, 14, 162
105Other: Fresh Frozen Plasma----1件: 14
106Other: Laboratory Biomarker Analysis----21件: 11, 13, 14, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331
107PANZYGA----1件: 14
108PARACETAMOLO----8件: 2, 11, 14, 28, 53, 61, 63, 300
109Peripheral Blood Stem Cell Transplantation----12件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286
110Placebo----27件: 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
111PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14
112PREDNISOLONE1件: Prednisolone8件: D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
113Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
114Prevenar 131件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---5件: 13, 14, 46, 96, 222
115Prevenar 13 sospensione per iniezione1件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---1件: 14
116PRIVIGEN1件: Human immunoglobulin G---4件: 11, 14, 51, 65
117Privigen®1件: Human immunoglobulin G---3件: 14, 63, 65
118Recombinant human hyaluronidase1件: Hyaluronidase (human recombinant)---3件: 14, 28, 65
119RHuPH20----2件: 13, 14
120Rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬49件: 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
121Rituximab (genetical recombination)1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 14
122ROZANOLIXIZUMAB1件: Rozanolixizumab1件: D12182 1件: FCGRT 💬-3件: 11, 14, 63
123RVG 51680----1件: 14
124RVG 56083----1件: 14
125SAR445088 (formerly BIVV020)----1件: 14
126Sodium chloride2件: Chloride ion,
Sodium chloride		1件: D02056 --21件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299
127Sodium Chloride 0.9%2件: Chloride ion,
Sodium chloride		1件: D02056 --2件: 14, 227
128SOLIRIS1件: Eculizumab1件: D03940 1件: C5 💬10件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222
129SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53
130Subcutaneous immunoglobulin----1件: 14
131Subcuvia----3件: 14, 49, 65
132Syngeneic Bone Marrow Transplantation----3件: 11, 13, 14
133TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE----1件: 14
134TAK-771----2件: 14, 65
135Tetanus toxoid1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---4件: 13, 14, 46, 50
136TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML----1件: 14
137UCB7665----3件: 11, 14, 63
138VACCINO PNEUMOCOCCICO SACCARIDICO----1件: 14
139Vivaglobin----2件: 14, 65